Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 27, 2014

New Stem Cell Manufacturing Center Launched in Ireland

  • The first facility in Ireland licensed to manufacture cultured stem cells for human use was launched today at the National University of Ireland at Galway (NUI Galway). The Centre for Cell Manufacturing will produce stem cells for use in clinical trials of new treatments for conditions such as heart disease, diabetes, and arthritis. The Irish Times reported that Ireland's Health Research Board and Science Foundation Ireland have approved funding at the Centre for trials using mesenchymal stem cells to treat critical limb ischemia, which is linked to diabetes.

    NUI Galway hopes that the Centre will help make Ireland a global leader in regenerative medicine. The Centre will be launched by Ireland's Minister for Research and Innovation Sean Sherlock at the Atrium, Orbsen Building at the University.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »